Omar A. Ibrahimi, Ph.D.
Affiliations: | 2004 | New York University, New York, NY, United States |
Area:
Biochemistry, PathologyGoogle:
"Omar Ibrahimi"Mean distance: (not calculated yet)
Parents
Sign in to add mentorMoosa Mohammadi | grad student | 2004 | NYU | |
(The FGF signaling pathway and human skeletal disorders.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Beenken A, Eliseenkova AV, Ibrahimi OA, et al. (2012) Plasticity in interactions of fibroblast growth factor 1 (FGF1) N terminus with FGF receptors underlies promiscuity of FGF1. The Journal of Biological Chemistry. 287: 3067-78 |
Gartside MG, Chen H, Ibrahimi OA, et al. (2009) Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Molecular Cancer Research : McR. 7: 41-54 |
Goetz R, Beenken A, Ibrahimi OA, et al. (2007) Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Molecular and Cellular Biology. 27: 3417-28 |
Pitteloud N, Quinton R, Pearce S, et al. (2007) Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism Journal of Clinical Investigation. 117: 457-463 |
Pitteloud N, Acierno JS, Meysing A, et al. (2006) Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proceedings of the National Academy of Sciences of the United States of America. 103: 6281-6 |
Zhang X, Ibrahimi OA, Olsen SK, et al. (2006) Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. The Journal of Biological Chemistry. 281: 15694-700 |
Olsen SK, Li JY, Bromleigh C, et al. (2006) Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain. Genes & Development. 20: 185-98 |
Pollock P, Gartside M, Ibrahimi O, et al. (2006) Functional characterization of FGFR2 mutations in melanoma reveals multiple mechanisms of inactivation Melanoma Research. 16: S97 |
Yu X, Ibrahimi OA, Goetz R, et al. (2005) Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23. Endocrinology. 146: 4647-56 |
Mohammadi M, Olsen SK, Ibrahimi OA. (2005) Structural basis for fibroblast growth factor receptor activation. Cytokine & Growth Factor Reviews. 16: 107-37 |